QuickView for NFkappaB IPT domain (biogroup)

1. L1000 CMAP - Amelanotic malignant melanoma of skin A375 cells treated with ligand perturbagens
2. Bone marrow-derived macrophage gene expression in response to treatment with LPS
3. T helper D10 cells time course TCR activation in the presence of Akt inhibition
4. Bone marrow- and peritoneal-derived mouse macrophages in resonse to a timecourse of LPS treatment
5. L1000 CMAP - Breast carcinoma BT20 cells treated with ligand perturbagens

There were no matches for NFkappaB IPT domain

There were no clinical trials for NFkappaB IPT domain